Advocacy Update Apr. 22, 2025
IN THIS ISSUE / Apr. 22, 2025
Dermatologists support truth in advertising bill in North Carolina
AADA advocates for reduced regulatory burden through information requests
AADA offers support, encourages CMS collaboration following Administrator Oz’s appointment
Regulatory Affairs
AADA urges CMS to amend CLIA lab director requirements
The AADA continues its opposition to the current CLIA lab director requirements, resulting in a second meeting with CMS on April 30. The AADA is calling upon CMS to recognize certification by the American Board of Dermatology or the American Osteopathic Board of Dermatology as qualifying credentials. In addition, the American Board of Dermatology sent a letter to CMS in support of the Academy’s position.
The AADA continues to fight for dermatologists to be recognized as lab directors under CLIA.
State Advocacy
Dermatologists support truth in advertising bill in North Carolina
Dermatologists in North Carolina joined (PDF) the AADA and the American Society for Dermatologic Surgery Association to support legislation (PDF) that would provide clarity to patients by limiting who can use the title “physician” in any title, advertisement, or other communication with the public. The bill also limits the use of the term “dermatologist” to individuals who practice medicine.
The AADA believes those who regulate and deliver medical care have an obligation to inform the public of the qualifications and limitations of the people providing their care prior to treatment. The AADA urges that all health care practitioners should clearly identify or disclose their degree or field of study, board-certification (if any), and licensure to each patient.
Regulatory Affairs
AADA advocates for reduced regulatory burden through information requests
Over the last few weeks, the Trump Administration has issued multiple requests for information (RFIs) and public inquiries to garner feedback on regulations that impose undue administrative burdens. The AADA is taking advantage of these RFIs to advance advocacy priorities aimed at reducing administrative burden, protecting patient access to dermatologic care, and ensuring that regulations do not inhibit innovation or interfere with clinical decision-making.
The recent RFIs include:
White House Office of Management and Budget RFI on “ideas for deregulation”
Department of Justice RFI on “laws and regulations that hinder free markets”
Federal Trade Commission request for public comment on “reducing anti-competitive regulatory barriers”
Centers for Medicare and Medicaid Services RFI on “regulatory relief”
Transition Update
AADA offers support, encourages CMS collaboration following Administrator Oz’s appointment
On April 15, the AADA congratulated (PDF) Mehmet Oz, MD, on his confirmation as Administrator of CMS. In the letter, the Academy welcomed the opportunity to collaborate with CMS on health care challenges and emphasized its commitment to advancing policies that improve patient care, promote public health, and support a more sustainable physician payment system. The AADA also offered to serve as a resource on issues such as Medicare payment reform, coverage policy, quality reporting, and other regulatory efforts that impact dermatology and the broader health care landscape. Administrator Oz acknowledged the letter, expressing appreciation for the Academy’s support for the work ahead.
AADA News
Join your colleagues and contribute to SkinPAC
As of April 17, SkinPAC has raised $586,611 from 586 individuals. Help us keep up the momentum as we advocate for Medicare physician payment reform. SkinPAC helps strengthen our relationships on Capitol Hill and reinforces our grassroots and lobbying efforts.
Contribute online at www.skinpac.org or by texting SkinPAC to 71777. Email skinpac@aad.org with any questions.
The political purpose of the American Academy of Dermatology Association Political Action Committee ("SkinPAC") is to solicit and receive contributions to be used to make political campaign expenditures to those candidates for elective office, and other federal political committees, who demonstrate understanding and interest in the view and goals of the American Academy of Dermatology Association.
Contributions to SkinPAC are not deductible for federal income tax purposes. Contributions to SkinPAC must be made from your funds and may not be reimbursed. SkinPAC cannot accept contributions from corporate accounts. Any recommended contribution amount is merely a suggestion. All AADA members have the right to contribute more or less or refuse to contribute without reprisal. Federal law prohibits us from accepting contributions from foreign nationals. Federal law requires us to use our best efforts to collect and report the name, physical address, occupation, and name of the employer whose contributions exceed $200 in a calendar year.
